CDB15:0001095 NGF — SORCS3

Experimentally validated in Human; Orthology-inferred in Mouse, Rat, Frog, Zebrafish, Chicken, Macaque, Pig, Dog, Cow, Chimp, Horse, Marmoset, Sheep

Title

Journal:; Year Published:

Abstract

SorCS3 does not require propeptide cleavage to bind nerve growth factor.

FEBS letters, 2005; PubMed, Homo sapiens NGF — Homo sapiens SORCS3
ABSTRACT: The functional properties of the Vps10p-domain receptor SorCS3 are undescribed. Here, we examine its processing and sorting in cellular transfectants, and analyze the binding of potential ligands to the purified receptor. We show that SorCS3 is synthesized as a proprotein and converted to its mature form by N-terminal propeptide cleavage in distal Golgi compartments. The propeptide is not a requirement for normal processing of the receptor and does not prevent ligands from binding to the SorCS3 precursor form. Expression of wt and chimeric receptors further suggests that SorCS3 predominates on the plasma membrane, exhibits slow internalization and does not engage in intracellular trafficking. SorCS3 emerges as a new neurotrophin binding Vps10p-domain receptor functionally distinct from its relatives Sortilin and SorLA.
Basic Information on NGF
Ligand Name: nerve growth factor
Other Symbols: NGFB
Ligand Location: secreted based on perplexity, uniprot
HGNC Gene Symbol Report: NGF
GeneCards: NGF
Interactions with other Receptors for NGF
Basic Information on SORCS3
Receptor Name: sortilin related VPS10 domain containing receptor 3
Other Symbols: KIAA1059, SORCS
Receptor Location: cell membrane based on perplexity
HGNC Gene Symbol Report: SORCS3
GeneCards: SORCS3
HGNC Gene Group: unknown
Interactions with other Ligands for SORCS3